Cardiology
News
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
News
COVID-19 at home: What does optimal care look like?
Most attention has focused on the sickest patients, leaving less severe cases to fall through the cracks.
News
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects
News
Early rhythm control in AFib gains new life
EAST-AFNET 4 trial reanimates rhythm-control strategy as superior for 5-year cardiovascular outcomes.
HM20 Virtual
Heart failure: Practice-changing developments for hospitalists
“I really like this H2FPEF score. The score works very, very well” for diagnosis of HFpEF – Dr. Dustin T. Smith
News
First evidence of SARS-CoV-2 in heart cells
SARS-CoV-2 has been found in cardiac tissue of a child with multisystem inflammatory syndrome related to COVID-19, believed to be first evidence...
HM20 Virtual
HM20 Virtual product theaters: Aug. 25-27
Attendees of HM20 Virtual can start their day with informative Product Theaters presented by SHM’s valued partners.
News
Oleander extract for COVID-19? That’s a hard ‘no’ experts say
Oleandrin poisoning may affect the central nervous system, as evidenced by drowsiness, tremors, seizures, collapse, and coma leading to death.
Clinical
PHM20 Virtual: Can’t miss heart disease for hospitalists
Congenital heart disease often presents with either cyanosis, hypoperfusion, failure to thrive, or respiratory distress.
News
Non-COVID-19 clinical trials grind to a halt during pandemic